Status:
RECRUITING
Effectiveness of a Zinc Oxide Adhesive Securement Device in the Fixation of Midline and Peripherally Inserted Central Catheters in Hospitalized Adult Patients
Lead Sponsor:
Hospital Arnau de Vilanova
Collaborating Sponsors:
Official College of Nurses of Lleida
Department of Health, Generalitat de Catalunya (PERIS)
Conditions:
Vascular Access Complication
Skin and Subcutaneous Tissue Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Study in which a zinc oxide fixation device (a product that can help protect the skin) for catheters (polyurethane tubes inserted into a vein) will be tested to reduce catheter-related complications: ...
Detailed Description
Introduction: Midline catheters (MLC) and peripherally inserted central catheters (PICC) are commonly used vascular access devices (VAD) in healthcare institutions where infusion therapies are require...
Eligibility Criteria
Inclusion Criteria:
- requiring cannulation of a midline catheter or a PICC
- who accepted and signed the informed consent voluntarily
- with an inpatient unit admission of minimum 7 days
Exclusion Criteria:
- patients with a known allergy to zinc oxide
Key Trial Info
Start Date :
February 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06770374
Start Date
February 1 2025
End Date
December 31 2026
Last Update
April 8 2026
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Arnau de Vilanova Hospital
Lleida, Catalonia, Spain, 25001
2
Hospital Universitari Arnau de Vilanova
Lleida, Catalonia, Spain, 25198